Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S9, 2019. DOI: 10.25251/skin.3.supp.9. Disponível em: https://skin.dermsquared.com/skin/article/view/736. Acesso em: 8 jun. 2025.